CCAAT/enhancer binding protein ε is a potential retinoid target gene in acute promyelocytic leukemia treatment
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
The CCAAT/enhancer binding protein epsilon (C/EBPepsilon) is a nuclear transcription factor expressed predominantly in myeloid cells and implicated as a potential regulator of myeloid differentiation. We show that it was rapidly induced in the acute promyelocytic leukemia (APL) cell line NB4 during granulocytic differentiation after exposure to retinoic acid (RA). Our data suggest that induction of C/EBPepsilon expression was through the retinoic acid receptor alpha (RARalpha) pathway. Reporter gene studies showed that C/EBPepsilon promoter/enhancer activity increased in a retinoid-dependent fashion via the retinoic acid response element (RARE) present in the promoter region of C/EBPepsilon. The RA-induced expression of C/EBPepsilon markedly increased in U937 myelomonoblasts that were induced to express promyelocytic leukemia/RARalpha (PML/RARalpha), but not in those induced to express promyelocytic leukemia zinc finger/RARalpha (PLZF/RARalpha). In retinoid-resistant APL cell lines, C/EBPepsilon either is not induced or is induced only at very high concentrations of RA (>/=10(-6) M). In addition, forced expression of C/EBPepsilon in the U937 myelomonoblastic leukemia cells mimicked terminal granulocytic differentiation, including morphologic changes, increased CD11b/CD66b expression, and induction of secondary granule protein expression. Our data strongly suggest that C/EBPepsilon is a downstream target gene responsible for RA-induced granulocytic differentiation of APL cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Differentiation induction of haematological malignant cells as well as normal HSC differentiation is mediated by a stochiometric ratio of transcription factors GATA-1 and PU.1 [41], which broadly determine lineage and cooperate with more specific transcription factors such as RAR receptor and CEBP family members [59, 93, 94].”
From PU.1 and partners: regulation of haematopoietic stem cell fate in normal and malignant haematopoiesis (2009) · cites this paper as [94]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Steroid and Thyroid Hormone Receptor Superfamily
Evans, R. M. (1988) · Science · doi:10.1126/science.3283939 · Cited by 7,439 · cited 1×
“Retinoids and their nuclear receptors appear to have multiple functions in the regulation of normal cellular differentiation (1).”
BackgroundUse of all-trans retinoic acid in the treatment of acute promyelocytic leukemia
Huang, M., Ye, Y., Chen, Sr., Chai, Jr., Lu, J., Zhoa, L., Gu, L., & Wang, Z. (1988) · Blood · doi:10.1182/blood.v72.2.567.567 · Cited by 2,445 · cited 1×
“Recently, all-trans retinoic acid (ATRA) has become a standard therapy for the induction of remissions in patients with acute promyelocytic leukemia (APL) (4, 5).”
Background9-cis retinoic acid is a high affinity ligand for the retinoid X receptor
Heyman, R. A., Mangelsdorf, D. J., Dyck, J. A., Stein, R. B., Eichele, G., Evans, R. M., & Thaller, C. (1992) · Cell · doi:10.1016/0092-8674(92)90479-v · Cited by 1,780 · cited 1×
“ATRA binds RAR but does not bind RXR; 9-cis retinoic acid (RA), a naturally occurring RA double-bond isomer, on the other hand, can bind to both RAR/RXR and RXR/RXR receptors (6, 7).”
BackgroundUmesono, K., Murakami, K. K., Thompson, C. C., & Evans, R. M. (1991) · Cell · doi:10.1016/0092-8674(91)90020-y · Cited by 1,716 · cited 2×
“The ligand-receptor complexes transactivate downstream genes that have RAR recognition sequences (8, 9).”
BackgroundMethodLuckow, B., & Schütz, G. (1987) · Nucleic Acids Research · doi:10.1093/nar/15.13.5490 · Cited by 1,701 · cited 6×
“A CAT reporter construct that does not contain a putative RARE site (PRE) was used as a negative control.”
MethodInfluentialKliewer, S. A., Umesono, K., Mangelsdorf, D. J., & Evans, R. M. (1992) · Nature · doi:10.1038/355446a0 · Cited by 1,489 · cited 1×
“The retinoic acid receptor (RAR) forms a heterodimeric complex with the retinoid X receptor (RXR) and has an important function in the transactivation of myeloid-specific genes (2, 3).”
BackgroundKakizuka, A., Miller, W. H., Umesono, K., Warrell, R. P., Frankel, S. R., Murty, V. V. V. S., Dmitrovsky, E., & Evans, R. M. (1991) · Cell · doi:10.1016/0092-8674(91)90112-c · Cited by 1,427
Self-citationde Thé, H., Chomienne, C., Lanotte, M., Degos, L., & Dejean, A. (1990) · Nature · doi:10.1038/347558a0 · Cited by 1,355 · cited 2×
“The ligand-receptor complexes transactivate downstream genes that have RAR recognition sequences (8, 9).”
BackgroundDifferentiation Therapy of Acute Promyelocytic Leukemia with Tretinoin (All-trans-Retinoic Acid)
Warrell, R. P., Frankel, S. R., Miller, W. H., Scheinberg, D. A., Itri, L. M., Hittelman, W. N., Vyas, R., Andreeff, M., Tafuri, A., Jakubowski, A., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199105163242002 · Cited by 1,251 · cited 1×
“Recently, all-trans retinoic acid (ATRA) has become a standard therapy for the induction of remissions in patients with acute promyelocytic leukemia (APL) (4, 5).”
BackgroundSelf-citation9-Cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRα
Levin, A. A., Sturzenbecker, L. J., Kazmer, S., Bosakowski, T., Huselton, C., Allenby, G., Speck, J., ratzeisen, C., Rosenberger, M., Lovey, A., et al. (1992) · Nature · doi:10.1038/355359a0 · Cited by 1,222 · cited 1×
“ATRA binds RAR but does not bind RXR; 9-cis retinoic acid (RA), a naturally occurring RA double-bond isomer, on the other hand, can bind to both RAR/RXR and RXR/RXR receptors (6, 7).”
BackgroundLeid, M., Kastner, P., Lyons, R., Nakshatri, H., Saunders, M., Zacharewski, T., Chen, J.-Y., Staub, A., Garnier, J.-M., Mader, S., et al. (1992) · Cell · doi:10.1016/0092-8674(92)90478-u · Cited by 1,166 · cited 1×
“The retinoic acid receptor (RAR) forms a heterodimeric complex with the retinoid X receptor (RXR) and has an important function in the transactivation of myeloid-specific genes (2, 3).”
BackgroundZhang, D.-E., Zhang, P., Wang, N.-D., Hetherington, C. J., Darlington, G. J., & Tenen, D. G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.569 · Cited by 910 · cited 6×
“t(15;17) marker isolated from a human acute promyelocytic leukemia (M3).”
BackgroundInfluentialLanotte, M., Martin-Thouvenin, V, Najman, S., Balerini, P., Valensi, F., & Berger, R. (1991) · Blood · doi:10.1182/blood.v77.5.1080.1080 · Cited by 883
Chen, G., Zhu, J., Shi, X., Ni, J., Zhong, H., Si, G., Jin, X., Tang, W., Li, X., Xong, S., et al. (1996) · Blood · doi:10.1182/blood.v88.3.1052.1052 · Cited by 864
Transcription Factors, Normal Myeloid Development, and Leukemia
Tenen, D. G., Hromas, R., Licht, J. D., & Zhang, D.-E. (1997) · Blood · doi:10.1182/blood.v90.2.489 · Cited by 735 · cited 1×
“1, AML1, CBFβ, Myb, and C/EBPα are implicated in granulocytic differentiation of hematopoietic stem cells (43, 44).”
BackgroundBirkenmeier, E. H., Gwynn, B., Howard, S., Jerry, J., Gordon, J. I., Landschulz, W. H., & McKnight, S. L. (1989) · Genes & Development · doi:10.1101/gad.3.8.1146 · Cited by 613 · cited 1×
“The members of the CCAAT/enhancer binding protein (C/EBP) family are implicated in the differentiation processes of a variety of mammalian cells including adipocytes, hepatocytes, and myeloid cells (13, 14).”
BackgroundGrignani, F., Ferrucci, P. F., Testa, U., Talamo, G., Fagioli, M., Alcalay, M., Mencarelli, A., Grignani, F., Peschle, C., Nicoletti, I., et al. (1993) · Cell · doi:10.1016/0092-8674(93)80044-f · Cited by 583 · cited 10×
“ATRA dose response studies with the U937PR9 cells demonstrated a 25-fold induction of C/EBPε at 10–8 M ATRA in the presence of PML/RARα, compared with a maximum of 2- to 3-fold induction without PML/RARα (Figure 3b).”
InfluentialThe transcriptional control of hematopoiesis [see comments]
Shivdasani, R., & Orkin, S. (1996) · Blood · doi:10.1182/blood.v87.10.4025.bloodjournal87104025 · Cited by 560 · cited 1×
“1, AML1, CBFβ, Myb, and C/EBPα are implicated in granulocytic differentiation of hematopoietic stem cells (43, 44).”
BackgroundPolarity-specific activities of retinoic acid receptors determined by a co-repressor
Kurokawa, R., Söderström, M., Hörlein, A., Halachmi, S., Brown, M., Rosenfeld, M. G., & Glass, C. K. (1995) · Nature · doi:10.1038/377451a0 · Cited by 547 · cited 1×
“Glutathione S-transferase (GST) fusion plasmids pGEX-RARα and pGEX-RXRα (36) were gifts from C.”
MethodAcute Myelogenous Leukemia: A Human Cell Line Responsive to Colony-Stimulating Activity
Koeffler, H. P., & Golde, D. W. (1978) · Science · doi:10.1126/science.306682 · Cited by 513 · cited 1×
“Additional cell lines were either established by our group (KG-1) (32) or obtained from American Type Culture Collection (Rockville, Maryland, USA).”
MethodSelf-citationCharacterization of a Zinc Finger Gene Disrupted by the t(15;17) in Acute Promyelocytic Leukemia
Goddard, A. D., Borrow, J., Freemont, P. S., & Solomon, E. (1991) · Science · doi:10.1126/science.1720570 · Cited by 458 · cited 1×
“APL is a subtype of myeloid leukemia characterized by a unique translocation between chromosomes 15 and 17, resulting in a fusion protein between promyelocytic leukemia (PML) and RARα (8, 10).”
BackgroundKastner, P., Perez, A., Lutz, Y., Rochette-Egly, C., Gaub, M. P., Durand, B., Lanotte, M., Berger, R., & Chambon, P. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05095.x · Cited by 415 · cited 4×
“Poor response to all-trans retinoic acid therapy in a t(11;17) PLZF/RARα patient.”
BackgroundInfluentialScott, L., Civin, C., Rorth, P., & Friedman, A. (1992) · Blood · doi:10.1182/blood.v80.7.1725.1725 · Cited by 409
Differential expression and ligand regulation of the retinoic acid receptor alpha and beta genes.
de The, H., Marchio, A., Tiollais, P., & Dejean, A. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03394.x · Cited by 394 · cited 1×
“The RARs, especially RARα, are expressed in most hematopoietic cell lineages and their respective cell lines (39).”
BackgroundYamanaka, R., Barlow, C., Lekstrom-Himes, J., Castilla, L. H., Liu, P. P., Eckhaus, M., Decker, T., Wynshaw-Boris, A., & Xanthopoulos, K. G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13187 · Cited by 383
Licht, J., Chomienne, C., Goy, A., Chen, A., Scott, A., Head, D., Michaux, J., Wu, Y., DeBlasio, A., & Miller, W. J. (1995) · Blood · doi:10.1182/blood.v85.4.1083.bloodjournal8541083 · Cited by 343
Self-citationHong, S.-H., David, G., Wong, C.-W., Dejean, A., & Privalsky, M. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.17.9028 · Cited by 340 · cited 1×
“PLZF/RARα has a retinoid-independent corepressor binding domain in the NH2-terminus (POZ domain) of PLZF, which may be the cause for retinoid resistance of these APL cells both in vivo and in vitro (49).”
BackgroundSmith, L., Hohaus, S., Gonzalez, D., Dziennis, S., & Tenen, D. (1996) · Blood · doi:10.1182/blood.v88.4.1234.bloodjournal8841234 · Cited by 332
PMLRAR homodimers: distinct DNA binding properties and heteromeric interactions with RXR.
Perez, A., Kastner, P., Sethi, S., Lutz, Y., Reibel, C., & Chambon, P. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05986.x · Cited by 292 · cited 1×
“PML (11, 12) and has the potential to interfere with the endogenous signaling pathways of both PML and RARα, thereby inhibiting terminal differentiation of hematopoietic precursor cell lines and promoting cell growth by blocking apoptotic cell death.”
BackgroundHohaus, S., Petrovick, M. S., Voso, M. T., Sun, Z., Zhang, D.-E., & Tenen, D. G. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.10.5830 · Cited by 284
Myb and NF-M: combinatorial activators of myeloid genes in heterologous cell types.
Ness, S. A., Kowenz-Leutz, E., Casini, T., Graf, T., & Leutz, A. (1993) · Genes & Development · doi:10.1101/gad.7.5.749 · Cited by 266 · cited 8×
“t(15;17) marker isolated from a human acute promyelocytic leukemia (M3).”
BackgroundInfluentialPandolfi, P. P., Alcalay, M., Fagioli, M., Zangrilli, D., Mencarelli, A., Diverio, D., Biondi, A., Lo Coco, F., Rambaldi, A., & Grignani, F. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05185.x · Cited by 262 · cited 1×
“U937PR9 cells express significantly higher induced levels of PML/RARα than endogenous RARα, similar to those observed in fresh APL blasts (29, 40).”
ResultRapid and efficient site-directed mutagenesis by single-tube 'megaprimer' PCR method
Ke, S. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.16.3371 · Cited by 251
C/EBP, c-Myb, and PU.1 Cooperate To Regulate the Neutrophil Elastase Promoter
Oelgeschläger, M., Nuchprayoon, I., Lüscher, B., & Friedman, A. D. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4717 · Cited by 229
Morosetti, R., Park, D. J., Chumakov, A. M., Grillier, I., Shiohara, M., Gombart, A. F., Nakamaki, T., Weinberg, K., & Koeffler, H. P. (1997) · Blood · doi:10.1182/blood.v90.7.2591 · Cited by 191
Self-citationYamanaka, R., Kim, G.-D., Radomska, H. S., Lekstrom-Himes, J., Smith, L. T., Antonson, P., Tenen, D. G., & Xanthopoulos, K. G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6462 · Cited by 180
Zhang, D., Hohaus, S., Voso, M. T., Chen, H.-M., Smith, L. T., Hetherington, C. J., & Tenen, D. G. (1996) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-85232-9_14 · Cited by 155
Shao, W., Benedetti, L., Lamph, W. W., Nervi, C., & Miller, W. H. (1997) · Blood · doi:10.1182/blood.v89.12.4282 · Cited by 147 · cited 3×
“Sequencing of PML/RARα from R4 showed a point mutation in the ligand-binding domain of the fusion gene (42).”
BackgroundMethodSelf-citationCloning of the Novel Human Myeloid-Cell-Specific C/EBP-ε Transcription Factor
Chumakov, A. M., Grillier, I., Chumakova, E., Chih, D., Slater, J., & Koeffler, H. P. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.3.1375 · Cited by 134
Self-citationTransactivational and DNA binding abilities of endogenous p53 in p53 mutant cell lines.
Park, D. J., Nakamura, H., Chumakov, A. M., SAID, J. W., Cw, M., Chen, D. L., & Koeffler, H. P. (1994) · PubMed · Cited by 128
Self-citationRuthardt, M., Testa, U., Nervi, C., Ferrucci, P. F., Grignani, F., Puccetti, E., Grignani, F., Peschle, C., & Pelicci, P. G. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.8.4859 · Cited by 127
Stat1 Is Induced and Activated by All-Trans Retinoic Acid in Acute Promyelocytic Leukemia Cells
Gianni, M., Terao, M., Fortino, I., LiCalzi, M., Viggiano, V., Barbui, T., Rambaldi, A., & Garattini, E. (1997) · Blood · doi:10.1182/blood.v89.3.1001 · Cited by 117
Antonson, P., Stellan, B., Yamanaka, R., & Xanthopoulos, K. G. (1996) · Genomics · doi:10.1006/geno.1996.0319 · Cited by 103
Transcriptional activation of the syndecan-1 promoter by the Wilms' tumor protein WT1.
Cook, D., Hinkes, M. T., Bernfield, M. R., & Rauscher, F. J. (1996) · PubMed · Cited by 96
Khanna-Gupta, A., Kolibaba, K., Zibello, T., & Berliner, N. (1994) · Blood · doi:10.1182/blood.v84.1.294.294 · Cited by 94
Poor response to all-trans retinoic acid therapy in a t(11;17) PLZF/RAR alpha patient.
Guidez, F., Huang, W., Tong, J., Dubois, C., Balitrand, N., Waxman, S., Michaux, J., Martiat, P., Degos, L., & Chen, Z. (1994) · PubMed · Cited by 79
Rosenauer, A., Raelson, J., Nervi, C., Eydoux, P., DeBlasio, A., & Miller, W. J. (1996) · Blood · doi:10.1182/blood.v88.7.2671.bloodjournal8872671 · Cited by 75 · cited 5×
“These sublines of NB4 cells express PML/RARα protein but have markedly decreased binding of ligand (31).”
BackgroundMethodInfluentialSelf-citationChih, D. Y., Chumakov, A. M., Park, D. J., Silla, A. G., & Koeffler, H. P. (1997) · Blood · doi:10.1182/blood.v90.8.2987 · Cited by 74 · cited 6×
“In addition, C/EBPε is transcriptionally upregulated by retinoids (22).”
BackgroundMethodInfluentialSelf-citationRapid Induction of CD38 Antigen on Myeloid Leukemia Cells by All trans-Retinoic Acid
Drach, J. W., Zhao, S. R., Malavasi, F., & Mehta, K. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.2080 · Cited by 72
Kizaki, M., Matsushita, H., Takayama, N., Muto, A., Ueno, H., Awaya, N., Kawai, Y., Asou, H., Kamada, N., & Ikeda, Y. (1996) · Blood · doi:10.1182/blood.v88.5.1824.1824 · Cited by 63
Chen, A., Licht, J. D., Wu, Y., Hellinger, N., Scher, W., & Waxman, S. (1994) · Blood · doi:10.1182/blood.v84.7.2122.2122 · Cited by 57
Testa, U., Grignani, F., Barberi, T., Fagioli, M., Masciulli, R., Ferrucci, P. F., Seripa, D., Camagna, A., Alcalay, M., & Pelicci, P. G. (1994) · PubMed · Cited by 54
Fraij, B. M., Birckbichler, P. J., Patterson, M. K., Lee, K. N., & Gonzales, R. A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41717-6 · Cited by 47
E3, a hematopoietic-specific transcript directly regulated by the retinoic acid receptor alpha
Scott, L. M., Mueller, L., & Collins, S. (1996) · Blood · doi:10.1182/blood.v88.7.2517.bloodjournal8872517 · Cited by 40
Coordinate Regulation of Neutrophil Secondary Granule Protein Gene Expression
Khanna‐Gupta, A., Zibello, T., & Berliner, N. (1996) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-85232-9_17 · Cited by 12 · cited 1×
“Leukemia cell lines, including HL60, NB4, and U937 cells, do not express secondary granule proteins such as human neutrophil lactoferrin and neutrophil collagenase (50, 51).”
Background
Research works printed but not linked: 6
- Zhang, 1996, Curr Top Microbiol Immunol, 211, 137
- Cook, 1996, Oncogene, 13, 1789
- Park, 1994, Oncogene, 9, 1899
- Guidez, 1994, Leukemia, 8, 312
- Testa, 1994, Cancer Res, 54, 4508
- Khanna-Gupta, 1996, Curr Top Microbiol Immunol, 211, 165
Cited by
CCAAT/enhancer-binding proteins: structure, function and regulation
RAMJI, D. P., & FOKA, P. (2002) · Biochemical Journal · doi:10.1042/bj20020508 · Cited by 1,400
Fazi, F., Rosa, A., Fatica, A., Gelmetti, V., De Marchis, M. L., Nervi, C., & Bozzoni, I. (2005) · Cell · doi:10.1016/j.cell.2005.09.023 · Cited by 894
Schug, T. T., Berry, D. C., Shaw, N. S., Travis, S. N., & Noy, N. (2007) · Cell · doi:10.1016/j.cell.2007.02.050 · Cited by 680
“Transcriptional activation by RAR may trigger differentiation (Park et al., 1999; Rochette-Egly and Chambon, 2001), cellcycle arrest (Donato et al.”
BackgroundDisruption of differentiation in human cancer: AML shows the way
Tenen, D. G. (2003) · Nature Reviews Cancer · doi:10.1038/nrc989 · Cited by 612
“For example, the ability of all- trans retinoic acid (ATRA) to induce differentiation of ACUTE PROMYELOCYTIC LEUKAEMIA (APL) cells might be mediated by C/EBP factors — most notably, C/EBPβ and C/EBP&epsi”
BackgroundZhang, P., Iwasaki-Arai, J., Iwasaki, H., Fenyus, M. L., Dayaram, T., Owens, B. M., Shigematsu, H., Levantini, E., Huettner, C. S., Lekstrom-Himes, J. A., et al. (2004) · Immunity · doi:10.1016/j.immuni.2004.11.006 · Cited by 504
Metadata
- Authors
- Park, D. J., Chumakov, A. M., Vuong, P. T., Chih, D. Y., Gombart, A. F., Miller, W. H., & Koeffler, H. P.
- Affiliations
- Cedars-Sinai Medical Center (US)
- Lady Davis Institute for Medical Research (CA)
- Corresponding author
- Park, Dorothy J.
- Venue
- Journal of Clinical Investigation
- Published
- 1999-05-15
- Volume
- 103
- Issue
- 10
- Pages
- 1399-1408
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC408448
- OpenAlex
- W2042117566
- Cited by
- 187
- References
- 55
- Citations by year
- 2025: 3 · 2024: 5 · 2023: 1 · 2022: 1 · 2021: 3 · 2020: 2 · 2019: 7 · 2018: 1 · 2017: 7 · 2016: 7 · 2015: 3 · 2014: 11 · 2013: 6 · 2012: 6
- FWCI
- 5.06
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Cedars-Sinai Medical Center
- National Institutes of Health
- University of California, Los Angeles
- Jonsson Comprehensive Cancer Center
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Keywords
- acute promyelocytic leukemia, retinoic acid, retinoic acid receptor alpha, retinoic acid response element, granulocytic differentiation, PML-RARα, PLZF-RARα, retinoid resistance, transcriptional regulation, myeloid differentiation, NB4 cells, U937 cells
- MeSH terms
- Retinoic Acid Receptor alpha, Cell Differentiation, DNA-Binding Proteins, Drug Resistance, Enhancer Elements, Genetic, Humans, Nuclear Proteins, Promoter Regions, Genetic, Retinoids, Tretinoin, Tumor Cells, Cultured, Leukemia, Promyelocytic, Acute, Gene Expression, Genes, Reporter, Receptors, Retinoic Acid, U937 Cells, CCAAT-Enhancer-Binding Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.